メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インスリン送達装置の世界市場の将来予測

Global Insulin Delivery Systems Market Forecast 2018-2026

発行 Inkwood Research 商品コード 563521
出版日 ページ情報 英文 132 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.89円で換算しております。
Back to Top
インスリン送達装置の世界市場の将来予測 Global Insulin Delivery Systems Market Forecast 2018-2026
出版日: 2018年08月10日 ページ情報: 英文 132 Pages
概要

当レポートでは、世界のインスリン送達装置 (インスリン・デリバリー・システム) 市場の将来展望について分析し、製品の特性や市場の基本構造、主な促進・抑制要因、市場全体および製品別・エンドユーザー別・地域別の市場動向見通し (今後9年間分)、市場の競争状態と求心力、主要企業のプロファイルなどを調査しております。

第1章 分析範囲

第2章 分析手法

第3章 エグゼクティブ・サマリー

第4章 市場の決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の課題

第5章 市場区分

  • 製品別
    • インスリンシリンジ
    • インスリンポンプ
    • インスリンペン
    • インスリン・ジェットインジェクター
  • エンドユーザー別
    • 在宅治療
    • 病院・クリニック
    • その他

第6章 主要指標

  • ポーターのファイブフォース分析
  • 市場機会マトリックス
  • バリューチェーン分析
  • ベンダー環境

第7章 地域分析

  • 北米 (米国、カナダ)
  • 欧州 (ドイツ、英国、フランスなど)
  • アジア太平洋地域 (中国、インド、オーストラリアなど)
  • ラテンアメリカ
  • 他の国々 (RoW)

第8章 企業プロファイル

目次
Product Code: 10536

KEY FINDINGS

The Global Insulin Delivery system market is predicted to flourish at an estimated CAGR of 9.10%. The easy availability of medication and delivery systems, prevailing incidences of type1 diabetes and the shifting focus towards self-management of diabetes can be credited for the market expansion.

MARKET INSIGHTS

The global insulin delivery system market is segmented on the basis of products and end users. The products are further divided into insulin pumps, insulin syringes, insulin pens, and insulin jet injectors. Of these, the Insulin pens are the most popular in the market. The end-users for the market include hospitals and clinics, home care and others. Hospitals are the leading end-users for the market since they utilize these delivery systems on a large scale and considerably engage with reimbursement authorities, government organizations and the suppliers for the same.

REGIONAL INSIGHTS

Geographically, the global Insulin delivery system market is segmented on the basis of four major regions including Asia-Pacific, Europe, North America, and the rest of the world. The Asia-Pacific region is predicted to be the fastest-growing region for the forecast period with India and China being its major contributor. However, the North American market is anticipated to hold the biggest share by 2026, owing to the rising prevalence of type 1 diabetes and the growing obese and overweight population. The increasing government support is also contributing to propel the market ahead.

COMPETITIVE INSIGHTS

Becton, Dickinson, and Company operates across Canada, US, Latin America, the Middle East & Africa, Europe, and the Asia Pacific. The company provides laboratory equipment and diagnostic products and devices for life science researchers, healthcare institutions, clinical laboratories, and the pharmaceutical industry. Some of the other leading market players include Animas Corporation (Johnson and Johnson), Tandem Diabetes Care, Eli Lilly And Company, Biocon Limited, Insulet Corporation, Novo Nordisk A/S, Medtronic Plc, Sanofi, and Ypsomed Holding Ag.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. RISE IN INCIDENCES OF DIABETES
    • 3.2.2. RISE IN AWARENESS OF THE GLUCOSE MONITORING DEVICES
    • 3.2.3. INSULIN PENS ARE THE LARGEST CONTRIBUTOR OF INSULIN DELIVERY MARKET

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. UPSURGE IN TYPE-1 DIABETES
    • 4.1.2. AVAILABILITY OF MEDICATION AND DELIVERY SYSTEMS AT THE ATTACHED PHARMACY STORES
    • 4.1.3. EMPHASIS ON SELF-MANAGEMENT OF DIABETES
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. STRINGENT GOVERNMENT REGULATIONS
    • 4.2.2. DEARTH OF INFORMATION
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. SWELLING RESEARCH AND DEVELOPMENT
    • 4.3.2. GROWING DIABETES ASSOCIATED HEALTH EXPENSES
  • 4.4. MARKET CHALLENGES
    • 4.4.1. RISE IN HEALTHCARE EXPENDITURE ON MEDICATION
    • 4.4.2. RISK OF SUBSTITUTES
    • 4.4.3. STRINGENT REIMBURSEMENT PROCEDURES
    • 4.4.4. COMPLICATIONS RELATED TO CERTAIN INSULIN DEVICES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY PRODUCT 2018-2026
    • 5.1.1. INSULIN SYRINGES
    • 5.1.2. INSULIN PUMPS
    • 5.1.3. INSULIN PENS
    • 5.1.4. INSULIN JET INJECTORS
  • 5.2. MARKET BY END USER 2018-2026
    • 5.2.1. HOME CARE
    • 5.2.2. HOSPITALS AND CLINICS
    • 5.2.3. OTHER END USERS

6. KEY ANALYTICAL

  • 6.1. PORTER'S 5 FORCE ANALYSIS
    • 6.1.1. BARGAINING POWER OF BUYERS
    • 6.1.2. BARGAINING POWER OF SUPPLIERS
    • 6.1.3. THREAT OF NEW ENTRANTS
    • 6.1.4. THREAT OF SUBSTITUTES
    • 6.1.5. COMPETITIVE RIVALRY
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. REGULATION OF BLOOD SUGAR
  • 6.4. KEY BUYING CRITERIA
  • 6.5. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. ITALY
    • 7.2.5. SPAIN
    • 7.2.6. RUSSIA
    • 7.2.7. REST OF EUROPE (ROE)
  • 7.3. ASIA-PACIFIC (APAC)
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. AUSTRALIA
    • 7.3.4. JAPAN
    • 7.3.5. SOUTH KOREA
    • 7.3.6. REST OF ASIA-PACIFIC (ROAP)
  • 7.4. REST OF THE WORLD (ROW)
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST AND AFRICA

8. COMPANY PROFILES

  • 8.1. ANIMAS CORPORATION (JOHNSON AND JOHNSON)
    • 8.1.1. COMPANY OVERVIEW
    • 8.1.2. PRODUCTS PORTFOLIO
    • 8.1.3. SWOT ANALYSIS
  • 8.2. BECTON, DICKINSON, AND COMPANY
    • 8.2.1. COMPANY OVERVIEW
    • 8.2.2. PRODUCTS PORTFOLIO
    • 8.2.3. SWOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. BIOCON LIMITED
    • 8.3.1. COMPANY OVERVIEW
    • 8.3.2. PRODUCTS PORTFOLIO
    • 8.3.3. SWOT ANALYSIS
    • 8.3.4. STRATEGIC INITIATIVES
  • 8.4. ELI LILLY AND COMPANY
    • 8.4.1. COMPANY OVERVIEW
    • 8.4.2. PRODUCTS PORTFOLIO
    • 8.4.3. SWOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. INSULET CORPORATION
    • 8.5.1. COMPANY OVERVIEW
    • 8.5.2. PRODUCTS PORTFOLIO
    • 8.5.3. SWOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. MEDTRONIC PLC
    • 8.6.1. COMPANY OVERVIEW
    • 8.6.2. PRODUCTS PORTFOLIO
    • 8.6.3. SWOT ANALYSIS
    • 8.6.4. STRATEGIC INITIATIVES
  • 8.7. NOVO NORDISK A/S
    • 8.7.1. COMPANY OVERVIEW
    • 8.7.2. PRODUCTS PORTFOLIO
    • 8.7.3. SWOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. SANOFI
    • 8.8.1. COMPANY OVERVIEW
    • 8.8.2. PRODUCTS PORTFOLIO
    • 8.8.3. SWOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. TANDEM DIABETES CARE, INC.
    • 8.9.1. COMPANY OVERVIEW
    • 8.9.2. PRODUCTS PORTFOLIO
    • 8.9.3. SWOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVES
  • 8.10. YPSOMED HOLDING AG
    • 8.10.1. COMPANY OVERVIEW
    • 8.10.2. PRODUCTS PORTFOLIO
    • 8.10.3. SWOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL INSULIN DELIVERY SYSTEMS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 2 DIABETES PREVALENCE IN VARIOUS GEOGRAPHIES 2015-2040 (MILLIONS)
  • TABLE 3 GLOBAL INSULIN DELIVERY SYSTEMS MARKET BY PRODUCT 2018-2026 ($ MILLION)
  • TABLE 4 GLOBAL INSULIN DELIVERY SYSTEMS MARKET BY END USER 2018-2026 ($ MILLION)
  • TABLE 5 GLOBAL INSULIN DELIVERY SYSTEMS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
  • TABLE 6 NORTH AMERICA INSULIN DELIVERY MARKET BY COUNTRIES 2018-2026 ($ MILLION)
  • TABLE 7 EUROPE INSULIN DELIVERY MARKET BY COUNTRIES 2018-2026 ($ MILLION)
  • TABLE 8 GERMANY DIABETIC STATISTICS 2015
  • TABLE 9 ASIA-PACIFIC INSULIN DELIVERY MARKET BY COUNTRIES 2018-2026 ($ MILLION)
  • TABLE 10 REST OF THE WORLD INSULIN DELIVERY MARKET BY COUNTRIES 2018-2026($ MILLION)
  • FIGURES LIST
  • FIGURE 1 GLOBAL INSULIN DELIVERY SYSTEMS MARKET 2018-2026 ($ MILLION)
  • FIGURE 2 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN INSULIN SYRINGES 2018-2026 ($ MILLION)
  • FIGURE 3 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN INSULIN PUMPS 2018-2026 ($ MILLION)
  • FIGURE 4 FACTORS CONSIDERED FOR MAKING AN IDEAL PEN
  • FIGURE 5 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN INSULIN PENS 2018-2026 ($ MILLION)
  • FIGURE 6 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN INSULIN JET INJECTORS 2018-2026 ($ MILLION)
  • FIGURE 7 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN HOME CARE 2018-2026 ($ MILLION)
  • FIGURE 8 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN HOSPITALS AND CLINICS 2018-2026 ($ MILLION)
  • FIGURE 9 GLOBAL INSULIN DELIVERY SYSTEMS MARKET IN OTHER END USERS 2018-2026 ($ MILLION)
  • FIGURE 10 THE UNITED STATES INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 11 CANADA INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 12 THE UNITED KINGDOM INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 13 FRANCE INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 14 GERMANY INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 15 ITALY INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 16 SPAIN INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 17 RUSSIA INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 18 REST OF EUROPE (ROE) INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 19 CHINA INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 20 INDIA INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 21 AUSTRALIA INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 22 JAPAN INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 23 SOUTH KOREA INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 24 REST OF ASIA-PACIFIC INSULIN DELIVERY MARKET 2018-2026($ MILLION)
  • FIGURE 25 LATIN AMERICA INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
  • FIGURE 26 MIDDLE EAST AND AFRICA INSULIN DELIVERY MARKET 2018-2026 ($ MILLION)
Back to Top